When was Clairvoyant Therapeutics founded?

Clairvoyant Therapeutics was founded in 2021 and raised its 1st funding round within a year of its incorporation.

Where is Clairvoyant Therapeutics located?

Clairvoyant Therapeutics is headquartered in Vancouver, Canada.

How many employees does Clairvoyant Therapeutics have?

As of Dec 31, 2024, the latest employee count at Clairvoyant Therapeutics is 11.

Is Clairvoyant Therapeutics a funded company?

Clairvoyant Therapeutics is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Nov 30, 2021.

When was the latest funding round of Clairvoyant Therapeutics?

Clairvoyant Therapeutics' latest funding was a $***** Seed round on Nov 30, 2021, with participation from 0 investor. Its primary sector is Neurology. In Canada, the Neurology sector has seen $177M in funding in 2026 to date.

Where does Clairvoyant Therapeutics rank among its competitors?

Clairvoyant Therapeutics ranks 3rd amongst 6 active competitors, none of which are funded.

Who are the top competitors of Clairvoyant Therapeutics?

Clairvoyant Therapeutics' top competitors include Clearmind, Entheon Biomedical and Alvarius. Among them, Entheon Biomedical secured the most recent funding round in January, 2025.

Clairvoyant Therapeutics - 2026 Company Profile, Funding & Competitors

Company Details

Website: clairvoyantrx.com
Social
Email ID: *****@clairvoyantrx.com

Key Metrics

Founded Year

2021

Location

Vancouver, Canada

Stage

Acquired

Total Funding

$2.35M in 1 round

Latest Funding Round

Seed, Nov 30, 2021, $*****

Ranked

3^rd among 6 active competitors

Employee Count

11 as on Dec 31, 2024

Similar Companies

Clearmind & 4 more

Exit Details

Acquired by Psyence Biomed (Sep 06, 2024)

View Clairvoyant Therapeutics' full profile

Clairvoyant Therapeutics got acquired by Psyence Biomed on Sep 06, 2024.

Click here to take a look at Clairvoyant Therapeutics's acquisition in detail

Clairvoyant Therapeutics has raised a total funding of $2.35M over 1 round.

Here is the list of recent funding rounds of Clairvoyant Therapeutics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 30, 2021	5021390	Seed	5532820	6008412	1281760	4603583

Access funding benchmarks and valuations. Sign up today!

View details of Clairvoyant Therapeutics's funding rounds and investors

Clairvoyant Therapeutics' employee count trend

Clairvoyant Therapeutics has 11 employees as of Dec 24. Here is Clairvoyant Therapeutics's employee count trend over the years:

Employee count trend for Clairvoyant Therapeutics

Uncover Clairvoyant Therapeutics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Clairvoyant Therapeutics include Clearmind, Entheon Biomedical and Alvarius. Here is the list of Top 10 competitors of Clairvoyant Therapeutics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Clearmind 2017, Vancouver (Canada), Public	Developer of psychedelic therapeutics for addiction and mental health conditions	$1.25M	Medigus, Aegis Capital & 1 others	53/100
2nd	Entheon Biomedical 2006, Vancouver (Canada), Acquired	Developer of psychedelic medicines for addiction disorders	$77.3K	Synaptic Ventures	39/100
3rd	Clairvoyant Therapeutics 2021, Vancouver (Canada), Acquired	Manufacturer of psychedelic therapy drug for addiction	$2.35M	-	29/100
4th	Alvarius 2017, Dublin (Ireland), Unfunded	Developer of psychedelic therapies for addiction	-	-	23/100
5th	Nirvana Life Science 2021, Vancouver (Canada), Public	Developer of therapeutics for the treatment of opioid addiction	-	ThreeD Capital	22/100
6th	Bmore 2020, Unfunded	Developer of synthetic psilocybin treatments for alcohol and substance disorders	-	-	16/100